Volume 24 - Issue 5 - May 2011
Feature »
Roundtable Insights On Treating Onychomycosis
Given the prevalence of onychomycosis and the emergence of laser therapy, these panelists review their approaches to managing onychomycosis, discuss ethical considerations with non-FDA approved modalities and emphasize the importance of establishing realistic patient expectations.
- « Previous
- | Page 3 of 3 |
- Next »







